Reply:
Peter Ferenci, Ludwig Kramer – 29 July 2008
Reply:
Robert J. Fontana – 29 July 2008
Reply:
Véronique Loustaud‐Ratti, Sophie Alain, Annick Rousseau, Pierre Marquet – 29 July 2008
Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome
Georgios N. Kalambokis, Epameinondas V. Tsianos – 29 July 2008
Which is the best way to analyze the efficacy of albumin dialysis in hepatic encephalopathy?
Rafael Bañares, Agustín Albillos, María‐Vega Catalina – 29 July 2008
Children with chronic hepatitis C: What future?
Raffaele Iorio, Francesco Cirillo, Vito Terlizzi, Antonietta Giannattasio – 29 July 2008
Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure
Chia‐Yen Dai, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Yen Hsieh, Ming‐Lung Yu – 29 July 2008
Short treatment to patients with genotype 2 or 3
Olav Dalgard, Alessandra Mangia – 29 July 2008
Hereditary hemochromatosis in the post‐HFE era
John K. Olynyk, Debbie Trinder, Grant A. Ramm, Robert S. Britton, Bruce R. Bacon – 16 July 2008 – Following the discovery of the HFE gene in 1996 and its linkage to the iron overload disorder hereditary hemochromatosis (HH) there have been profound developments in our understanding of the pathogenesis of the biochemical and clinical manifestations of a number of iron overload disorders.
Reply:
Chia‐Ming Chu – 16 July 2008